The multidisciplinary research group works on developing controlled drug delivery systems through various routes of administration to improve patients' quality of life. Their areas of expertise include ocular and transdermal drug delivery, absorption enhancement, iontophoresis, and prediction of skin and ocular penetration and bioavailability. They have 18 years of experience in multidisciplinary drug delivery research and focus on developing drugs, therapeutic systems, and medical devices for long-term diseases. Their research interests include transdermal and ocular delivery systems allowing modified drug release, as well as innovative 3D printed systems using new active substances and biomaterials.